C. Lindsay DeVane, PharmD: Charleston Antidepressant Drug Interactions Surveillance Program (CADISP)

Name: C. Lindsay DeVane, PharmD: Charleston Antidepressant Drug Interactions Surveillance Program (CADISP)
SKU: 3345
Availability: InStock

$30.00

Want a discount? Become a member by purchasing Psychopharmacology Bulletin Subscription - Individual!

Categories: Psychopharmacology Bulletin, VOL 35 No. 2 Articles Tags: c-lindsay-devane, cytochrome-p-450, drug-interactions, heidi-l-liston, john-s-markowitz, medworks-media, nefazodone, pharmacokinetics, psychopharmacology-bulletin, s-craig-risch, ssri, venlafaxine

Description

C. Lindsay DeVane, PharmD: Charleston Antidepressant Drug Interactions Surveillance Program (CADISP)

Description

C. Lindsay DeVane, PharmD

DRUG INTERACTIONS

Charleston Antidepressant Drug Interactions Surveillance Program (CADISP)

C. Lindsay DeVane, PharmD, John S. Markowitz, PharmD, Heidi L. Liston, PharmD, and S. Craig Risch, MD

Paliperidone Double-blind, Placebo- and Active-Controlled, Study

What Mood Symptoms may be most Difficult to Rate?

Schizophrenia Rating Scales Critical Review by Takefumi Suzuki

Trazodone for Depressed Mood, Anxiety, Insomnia, and Suicidality

C. Lindsay DeVane, PharmD: Charleston Antidepressant Drug Interactions Surveillance Program (CADISP)

Description

C. Lindsay DeVane, PharmD

DRUG INTERACTIONS

Charleston Antidepressant Drug Interactions Surveillance Program (CADISP)

C. Lindsay DeVane, PharmD, John S. Markowitz, PharmD, Heidi L. Liston, PharmD, and S. Craig Risch, MD

Related products

Paliperidone Double-blind, Placebo- and Active-Controlled, Study

What Mood Symptoms may be most Difficult to Rate?

Schizophrenia Rating Scales Critical Review by Takefumi Suzuki

Trazodone for Depressed Mood, Anxiety, Insomnia, and Suicidality